DK0983237T3 - Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner - Google Patents

Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner

Info

Publication number
DK0983237T3
DK0983237T3 DK98929307T DK98929307T DK0983237T3 DK 0983237 T3 DK0983237 T3 DK 0983237T3 DK 98929307 T DK98929307 T DK 98929307T DK 98929307 T DK98929307 T DK 98929307T DK 0983237 T3 DK0983237 T3 DK 0983237T3
Authority
DK
Denmark
Prior art keywords
pyridines
fluorophenyl
tetrahydro
hydroxymethyl
substituted
Prior art date
Application number
DK98929307T
Other languages
English (en)
Inventor
James Patrick Brennan
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0983237T3 publication Critical patent/DK0983237T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98929307T 1997-05-17 1998-05-13 Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner DK0983237T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710004.4A GB9710004D0 (en) 1997-05-17 1997-05-17 Chemical process
PCT/EP1998/002826 WO1998052920A1 (en) 1997-05-17 1998-05-13 Chemical process for the reduction of 1-substituted -3-hydroxymethyl-4- (4-fluorophenyl)tetrahydropyridines

Publications (1)

Publication Number Publication Date
DK0983237T3 true DK0983237T3 (da) 2002-03-25

Family

ID=10812456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98929307T DK0983237T3 (da) 1997-05-17 1998-05-13 Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner

Country Status (28)

Country Link
US (1) US6326496B1 (da)
EP (1) EP0983237B1 (da)
JP (1) JP4463883B2 (da)
KR (1) KR100515852B1 (da)
CN (1) CN1121386C (da)
AR (1) AR012688A1 (da)
AT (1) ATE212013T1 (da)
AU (1) AU748902B2 (da)
BG (1) BG63847B1 (da)
BR (1) BR9809809B1 (da)
CA (1) CA2289013C (da)
CZ (1) CZ292282B6 (da)
DE (1) DE69803178T2 (da)
DK (1) DK0983237T3 (da)
ES (1) ES2171299T3 (da)
GB (1) GB9710004D0 (da)
HU (1) HUP0002709A3 (da)
ID (1) ID24181A (da)
IL (1) IL132360A (da)
NO (1) NO313326B1 (da)
NZ (1) NZ501692A (da)
PL (1) PL189464B1 (da)
PT (1) PT983237E (da)
RU (1) RU2205178C2 (da)
SK (1) SK149599A3 (da)
TR (1) TR199902823T2 (da)
UA (1) UA61952C2 (da)
WO (1) WO1998052920A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280775A1 (en) * 2000-05-12 2003-02-05 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
GB0021147D0 (en) 2000-08-30 2000-10-11 Knoll Ag Chemical process
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
US6930186B2 (en) * 2001-06-13 2005-08-16 Teva Pharmacetical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
WO2007058998A2 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849542A (en) 1966-05-09 1974-11-19 Dow Chemical Co Lithium magnesium aluminum hydride
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
GB9100505D0 (en) * 1991-01-10 1991-02-20 Shell Int Research Piperidine derivatives
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
BR9608471A (pt) * 1995-05-17 1998-12-29 Novo Nordisk As Processo para a preparação de um composto
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
HU221921B1 (hu) 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
PL189464B1 (pl) 2005-08-31
CA2289013A1 (en) 1998-11-26
BG63847B1 (bg) 2003-03-31
CZ292282B6 (cs) 2003-08-13
EP0983237B1 (en) 2002-01-16
GB9710004D0 (en) 1997-07-09
HUP0002709A1 (hu) 2001-01-29
BR9809809A (pt) 2000-06-27
DE69803178T2 (de) 2002-10-31
CA2289013C (en) 2007-11-13
CN1255916A (zh) 2000-06-07
NZ501692A (en) 2001-05-25
PL336796A1 (en) 2000-07-17
KR20010012620A (ko) 2001-02-26
AR012688A1 (es) 2000-11-08
NO313326B1 (no) 2002-09-16
HUP0002709A3 (en) 2002-01-28
TR199902823T2 (xx) 2000-05-22
DE69803178D1 (de) 2002-02-21
AU748902B2 (en) 2002-06-13
SK149599A3 (en) 2000-05-16
JP4463883B2 (ja) 2010-05-19
KR100515852B1 (ko) 2005-09-21
UA61952C2 (en) 2003-12-15
IL132360A0 (en) 2001-03-19
BG103834A (en) 2000-07-31
US6326496B1 (en) 2001-12-04
ES2171299T3 (es) 2002-09-01
NO995619L (no) 1999-11-16
CN1121386C (zh) 2003-09-17
PT983237E (pt) 2002-05-31
AU7912198A (en) 1998-12-11
ATE212013T1 (de) 2002-02-15
RU2205178C2 (ru) 2003-05-27
JP2001525838A (ja) 2001-12-11
EP0983237A1 (en) 2000-03-08
WO1998052920A1 (en) 1998-11-26
BR9809809B1 (pt) 2009-05-05
NO995619D0 (no) 1999-11-16
CZ408199A3 (cs) 2000-04-12
IL132360A (en) 2003-02-12
ID24181A (id) 2000-07-13

Similar Documents

Publication Publication Date Title
DK1071745T3 (da) Fremgangsmåde til syntetisering af COX-2-inhibitorer
DK1038008T3 (da) Fremgangsmåde til fremstilling af EGIII-lignende enzymer
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
NO995077L (no) Fremgangsmåte ved anvendelse av cyklooksygenase-2 inhibitorer
NO20006499D0 (no) Metode for overföring av informasjon
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0923978T3 (da) Fremgangsmåde til behandling af röggas
DK0930091T3 (da) Fremgangsmåde til behandling af röggasser
ID26400A (id) Alat dan metode pengoreksi kesalahan bentuk luar
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
DK1042228T3 (da) Fremgangsmåde til behandling af cementslam
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0987356T3 (da) Fremgangsmåde til trækning
NO995619D0 (no) Kjemisk fremgangsmåte for fremstilling av 1-substituerte 3-hydroksymetyl-4-(4-fluorfenyl)tetrahydropyridiner
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK0862939T3 (da) Fremgangsmåde til behandling af röggas
DK1131299T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5- eller 3-hydroxypyrazoler
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1607090T3 (da) Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)
ID24281A (id) Metoda pembakaran suatu reaksi kimia secara induksi
DK1095035T3 (da) Fremgangsmåde til fremstilling af 4-(3-pyridinyl)-1H-imidazol og de anvendte mellemprodukter
ATE233323T1 (de) Verfahren zur präparation von enantiomer- angereicherten, n-derivatisierten laktamen.
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
ITBO970057A0 (it) Metodo di controllo di sigarette.
NO990614D0 (no) FremgangsmÕte ved sammenf°yning av metallmateriale